Application Nr Approved Date Route Status External Links
NDA203168 None Ophthalmic None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Prolensa (Bromfenac Ophthalmic Solution) 0.07% Is Indicated For The Treatment Of Postoperative Inflammation And Reduction Of Ocular Pain In Patients Who Have Undergone Cataract Surgery. Prolensa Is A Nonsteroidal Anti-Inflammatory Drug (Nsaid) Indicated For The Treatment Of Postoperative Inflammation And Reduction Of Ocular Pain In Patients Who Have Undergone Cataract Surgery. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Bromfenac Sodium BROMFENAC SODIUM ZINC2570817

Comments